OMER Executive Compensation

* In USD (Original Currency)
Filing Date
(SEC Report)
Year Reporting Name Salary Bonus Stock Award Incentive Plan Compensation Other Compensation Total
2023-05-17 2021 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 401,700 97,000 0 0 6,625 1,278,638
2023-05-17 2020 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 384,016 153,178 0 0 6,555 1,093,964
2023-05-17 2022 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 429,936 81,120 0 0 7,541 771,511
2023-05-17 2020 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 817,405 1,400,000 0 0 20,654 5,775,149
2023-05-17 2021 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 848,103 875,000 0 0 21,609 7,415,675
2023-05-17 2022 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 882,027 890,000 0 0 22,607 3,728,686
2023-05-17 2021 Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary 381,600 90,000 0 0 6,594 1,251,507
2023-05-17 2020 Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary 345,000 57,500 0 0 6,607 943,719
2023-05-17 2022 Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary 417,960 77,760 0 0 7,516 741,273
2022-05-02 2020 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 384,016 153,178 0 0 6,555 1,093,964
2022-05-02 2021 Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary 381,600 90,000 0 0 6,594 1,251,507
2022-05-02 2020 Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary 345,000 57,500 0 0 6,607 943,719
2022-05-02 2019 Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary 287,500 15,000 0 0 5,413 705,959
2022-05-02 2021 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 848,103 875,000 0 0 21,609 7,415,675
2022-05-02 2021 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 401,700 97,000 0 0 6,625 1,278,638
2022-05-02 2019 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 793,597 0 0 0 20,217 4,825,134
2022-05-02 2020 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 817,405 1,400,000 0 0 20,654 5,775,149
2022-05-02 2019 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 363,398 0 0 0 6,556 983,450
2021-04-30 2019 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 793,597 0 0 0 20,217 4,825,134
2021-04-30 2020 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 817,405 1,400,000 0 0 20,654 5,775,149
2021-04-30 2018 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board 770,483 700,000 0 0 19,581 4,740,339
2021-04-30 2020 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 384,016 153,178 0 0 6,555 1,093,964
2021-04-30 2019 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 363,398 0 0 0 6,556 983,450
2021-04-30 2018 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 352,814 69,010 0 0 6,630 985,644
2021-04-30 2020 Peter B. Cancelmo, J.D. Vice President, General Counsel 345,000 57,500 0 0 6,607 943,719
2021-04-30 2019 Peter B. Cancelmo, J.D. Vice President, General Counsel 287,500 15,000 0 0 5,413 705,959
2020-04-29 2018 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 352,814 69,010 0 0 6,630 985,644
2020-04-29 2019 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 363,398 0 0 0 6,556 983,450
2020-04-29 2017 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 748,041 901,725 0 0 20,555 4,535,284
2020-04-29 2018 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 770,483 700,000 0 0 19,581 4,740,339
2020-04-29 2019 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 793,597 0 0 0 20,217 4,825,134
2020-04-29 2017 Marcia S. Kelbon, J.D., M.S. Former Vice President, Patents, General Counsel and Secretary 381,287 258,121 0 0 6,651 1,219,052
2020-04-29 2018 Marcia S. Kelbon, J.D., M.S. Former Vice President, Patents, General Counsel and Secretary 397,095 77,671 0 0 6,693 1,085,082
2020-04-29 2019 Marcia S. Kelbon, J.D., M.S. Former Vice President, Patents, General Counsel and Secretary 409,008 90,002 0 0 6,618 1,119,124
2020-04-29 2019 Peter B. Cancelmo, J.D. 287,500 15,000 0 0 5,413 705,959
2020-04-29 2017 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 338,769 136,179 0 0 6,586 1,016,327
2019-04-29 2017 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2019-04-29 2016 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2019-04-29 2016 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2019-04-29 2016 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2019-04-29 2017 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2019-04-29 2018 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2019-04-29 2017 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2019-04-29 2018 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2019-04-29 2018 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2018-04-30 2017 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 338,769 136,179 0 0 6,586 1,016,327
2018-04-30 2017 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 748,041 901,725 0 0 20,555 4,535,283
2018-04-30 2016 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 776,918 248,595 0 0 15,163 6,380,956
2018-04-30 2015 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 669,500 0 0 0 14,092 683,592
2018-04-30 2016 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 336,778 51,880 0 0 2,573 1,526,041
2018-04-30 2015 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 285,000 0 0 0 2,545 287,545
2018-04-30 2017 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 381,287 258,121 0 0 6,651 1,219,051
2018-04-30 2016 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 400,412 64,061 0 0 2,619 1,535,148
2018-04-30 2015 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 345,050 0 0 0 2,640 347,690
2017-04-25 2016 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 336,778 51,880 0 0 2,573 1,526,041
2017-04-25 2014 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 352,587 0 0 0 2,456 1,146,240
2017-04-25 2015 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 345,050 0 0 0 2,640 347,690
2017-04-25 2016 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 400,412 64,061 0 0 2,619 1,535,148
2017-04-25 2014 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 285,000 0 0 0 2,398 1,007,118
2017-04-25 2015 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 285,000 0 0 0 2,545 287,545
2017-04-25 2016 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 776,918 248,595 0 0 15,163 6,380,956
2017-04-25 2015 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 669,500 0 0 0 14,092 683,592
2017-04-25 2014 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 684,125 0 0 0 17,195 3,938,035
2016-04-22 2015 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2016-04-22 2013 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2016-04-22 2014 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2016-04-22 2015 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2016-04-22 2013 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2016-04-22 2014 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2016-04-22 2015 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2016-04-22 2013 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2016-04-22 2014 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2015-04-23 2012 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 655,500 108,150 0 0 18,342 3,534,927
2015-04-23 2013 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 79,745 0 0 0 717 787,233
2015-04-23 2012 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2015-04-23 2014 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 352,587 0 0 0 2,456 1,146,240
2015-04-23 2013 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 335,000 0 0 0 2,169 1,037,605
2015-04-23 2012 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 338,050 55,878 0 0 3,539 1,399,656
2015-04-23 2014 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 684,125 0 0 0 17,195 3,938,035
2015-04-23 2013 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 650,000 0 0 0 14,881 3,236,359
2015-04-23 2014 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 285,000 0 0 0 2,398 1,007,118
2014-04-24 2013 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 664,625 0 0 0 14,881 3,250,984
2014-04-24 2012 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 338,050 55,878 0 0 3,539 1,399,656
2014-04-24 2013 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 342,538 0 0 0 2,169 1,045,143
2014-04-24 2011 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2014-04-24 2012 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 0 0 0 0 0 0
2014-04-24 2013 Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer 79,745 0 0 0 717 786,516
2014-04-24 2011 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 600,000 0 0 0 17,349 617,349
2014-04-24 2012 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 655,500 108,150 0 0 18,342 3,534,927
2014-04-24 2011 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 310,000 0 0 0 3,813 313,813
2013-04-24 2011 Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors and Interim Chief Financial Officer and Treasurer 600,000 0 0 0 17,349 617,349
2013-04-24 2012 Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors and Interim Chief Financial Officer and Treasurer 655,500 108,150 0 0 18,342 3,534,927
2013-04-24 2010 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 305,833 0 0 47,244 3,729 734,365
2013-04-24 2011 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 310,000 0 0 0 3,813 313,813
2013-04-24 2012 Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary 338,050 55,878 0 0 3,539 1,399,656
2013-04-24 2010 Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors and Interim Chief Financial Officer and Treasurer 579,167 0 0 91,440 23,635 2,093,530
2012-04-27 2009 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 285,000 0 0 0 3,672 288,672
2012-04-27 2010 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 305,833 0 0 47,244 3,729 734,365
2012-04-27 2011 Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors 600,000 0 0 0 17,349 617,349
2012-04-27 2010 Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors 579,167 0 0 91,440 23,635 2,093,530
2012-04-27 2009 Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors 475,000 0 0 0 14,003 489,003
2012-04-27 2011 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 310,000 0 0 0 3,813 313,813
2011-04-27 2010 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 305,833 0 0 47,244 3,729 734,365
2011-04-27 2008 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 285,000 0 0 0 3,049 288,049
2011-04-27 2010 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 579,167 0 0 91,440 23,635 2,093,530
2011-04-27 2009 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 475,000 0 0 0 14,003 489,003
2011-04-27 2008 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 475,000 0 0 0 25,255 500,255
2011-04-27 2009 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 285,000 0 0 0 3,672 288,672
2010-04-28 2008 Richard J. Klein Chief Financial Officer and Treasurer 0 0 0 0 0 0
2010-04-28 2009 Richard J. Klein Chief Financial Officer and Treasurer 0 0 0 0 0 0
2010-04-28 2007 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2010-04-28 2008 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0
2010-04-28 2009 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2010-04-28 2008 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2010-04-28 2007 Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors 0 0 0 0 0 0
2010-04-28 2009 Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary 0 0 0 0 0 0

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.